In a significant legal victory for Microsoft, the U.S. Court of Appeals for the Federal Circuit has reversed and remanded the validity and inequitable conduct issues in a $521 million patent lawsuit over the software maker’s browser technology.
The recording industry has appealed a federal court's ruling that it can't compel internet service providers to identify music downloaders under the 1988 Digital Millennium Copyright Act.
U.S. Commerce Secretary Carlos M. Gutierrez has appointed three new members each to the Patent Public Advisory Committee and the Trademark Public Advisory Committee.
A software vendor that has rattled the futures industry with threats of patent litigation has sued a broker with clients trading on all four of the leading futures exchanges.
Pharma and biotech patent litigator Thomas Beck has left Fitzpatrick Cella Harper & Scinto to join Sidley Austin Brown & Wood LLP as a partner.
In a move that could wipe out much of Canada’s billion-dollar internet pharmacy industry, the government is considering banning the export of patented prescription drugs to the U.S.
Attorneys for Compuware told a jury that IBM stole its trade secrets as part of a plan to wipe out the software maker, as the trial phase got underway in the closely watched trade-secrets and copyright infringement lawsuit.
A federal court in Illinois has awarded Swanson Tool Company more than $600,000 in a trademark counterfeiting lawsuit which remains pending against several other defendants.
A federal judge has denied Trading Technologies’ motion for an injunction against Cantor Fitzgerald's eSpeed derivatives division, but acknowledged in his decision that there is “a clear showing of patent validity and infringement.”
Duane Morris has hired another former Kenyon & Kenyon litigator to join its patent litigation practice in New York.
In a deal that closely resembles similar settlements for arthritis drug Relafen and prescription antibiotic Augmentin, GlaxoSmithKline has reportedly agreed to pay $65 million to settle a class action antitrust suit brought by consumers who accused the U.K. drug maker of filing "sham" patent lawsuits to delay generic competition for antidepressant Paxil.
Former Baker Botts LLP partner Rochelle K. Seide has joined Arent Fox PLLC’s intellectual property practice in New York.
Trademark expert Christopher J. Schulte has left trial law firm Meagher & Geer to join intellectual property specialist Merchant & Gould as a partner in its Minneapolis office.
Multimedia software maker Ingenient Technologies Inc. has sued rival PacketVideo and two former employees for copyright infringement and misappropriation of trade secrets.
The U.S. Court of Appeals for the Eighth Circuit has upheld a lower court’s determination that Natural Biologics misappropriated trade secrets from drug maker Wyeth for a hormone replacement treatment, dealing a blow to generic maker Barr Pharma’s attempts to make a generic version of the drug Premarin.
Veteran intellectual property attorneys William Kircher and Richard Johnson have left Shook Hardy & Bacon to join Blackwell Sanders Peper Martin in Kansas City, stripping Shook Hardy of the last name partners of a boutique it acquired five years ago.
As competition becomes increasingly fierce in the intellectual property field, a few firms are experimenting with more aggressive marketing approaches.
Davis Wright Tremaine LLP has hired two patent attorneys from Pillsbury Winthrop for its Los Angeles office.
Biotech company Mergen Ltd. has agreed to take a license to settle U.K.-based Oxford Gene Technology’s patent infringement lawsuit, the company said.
In a blow to U.K. drug maker GlaxoSmithKline PLC, the European Court of Justice has ruled that generic drug makers should be allowed to market versions of its top-selling anti-depressant Seroxat, marketed in the U.S. as Paxil.